(secondQuint)A Study of Azithromycin in HIV-Infected Patients.

 The need exists to further assess the antibacterial agent azithromycin at differing doses in an HIV-infected population.

 Patients are randomized to receive azithromycin at 1 of 2 doses in a two-treatment, two-period, cross-over study.

 Dosing visits are separated by at least 14-day wash-out periods.

.

 A Study of Azithromycin in HIV-Infected Patients@highlight

To assess the dose proportionality of azithromycin concentrations and toleration when delivered in tablet formulation to HIV-infected patients.

 The need exists to further assess the antibacterial agent azithromycin at differing doses in an HIV-infected population.

